Proteolytically cleaved mutant antithrombin-Hamilton has high stability to denaturation characteristic of wild type inhibitor serpins (Q45087415)

9 December 2017

Proteolytically cleaved mutant antithrombin-Hamilton has high stability to denaturation characteristic of wild type inhibitor serpins (English)

1 reference

9 December 2017

1 reference

Wright HT

1

1 reference

PubMed ID

8026575

9 December 2017

Blajchman MA

series ordinal

2

1 reference

PubMed ID

8026575

9 December 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

9 December 2017

1 reference

9 December 2017

348

1 reference

9 December 2017

1

1 reference

9 December 2017

14-16

1 reference

Structure and variation of human alpha 1-antitrypsin

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Human plasma proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Crystal structure of ovalbumin as a model for the reactive centre of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Effects of mutations in the hinge region of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Hormone binding globulins undergo serpin conformational change in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

The structural basis for neutrophil inactivation of C1 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Ovalbumin and angiotensinogen lack serpin S-R conformational change

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Structural basis of latency in plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Inhibitory activity and conformational transition of alpha1-proteinase inhibitor variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Mobile reactive centre of serpins and the control of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Release of a Two-Chain Form of Antithrombin from the Antithrombin-Thrombin Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Evidence for the extent of insertion of the active site loop of intact alpha 1 proteinase inhibitor in beta-sheet A

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Site-directed mutagenesis of alanine-382 of human antithrombin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

Properties of thrombin- and elastase-modified human antithrombin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900568-0

10.1016/0014-5793(94)00568-0

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

8026575